Potentiation of responses to and inhibition of extraneuronal metabolism of catecholamines by veratrine.
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D001011:Aorta / Q000187:drug effects; D065098:Catechol O-Methyltransferase Inhibitors; D004357:Drug Synergism; D004837:Epinephrine / Q000378:metabolism / Q000494:pharmacology*; D066298:In Vitro Techniques; D008729:Methoxamine / Q000494:pharmacology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism / Q000494:pharmacology*; D009647:Normetanephrine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011817:Rabbits; D013578:Synephrine / Q000494:pharmacology; D014702:Veratrine / Q000494:pharmacology
D000470:Alkaloids; D065098:Catechol O-Methyltransferase Inhibitors; D008996:Monoamine Oxidase Inhibitors; D009647:Normetanephrine; D010656:Phenylephrine; D014702:Veratrine; D008729:Methoxamine; D013578:Synephrine; D009638:Norepinephrine; D004837:Epinephrine